Segment Information

12 Months Ended

Jun. 30, 2018

Segment Reporting [Abstract]

Segment Information

10. SEGMENT INFORMATION

SFAS No. 131, “Disclosures About Segments of an Enterprise and Related Information,” requires that companies disclose segment data based on how management makes decisions about allocating resources to segments and measuring their performance. Currently, we conduct our businesses in three operating segments – Land & Hospitality, Medical Device and Pharmaceutical, and Other Services. Our Land & Hospital and Other Services business units operate in the United States. Our Medical Device and Pharmaceutical business unit currently operates primarily in the United Kingdom. All remaining assets, primarily our corporate offices and investment portfolio, are located in the United States. The segment classified as Corporate includes corporate operating activities that support the executive offices, capital structure and costs of being a public registrant. These costs are not allocated to the operating segments when determining profit or loss. The following table reflects our segments as of June 30, 2018 and 2017 and for the twelve month periods then ended.

				MEDICAL
Year ended	LAND &			DEVICE &			OTHER
June 30, 2018	HOSPITALITY			PHARMA			SERVICES			CORPORATE			TOTAL
Operating revenues, gross	$	67,160		$	317,119		$	-		$	-		$	384,279
Operating revenues, net	$	67,160		$	208,685		$	-		$	-			275,845
Operating income (loss)		(22,443	)	$	(217,174	)	$	(1,791	)	$	(196,256	)	$	(437,664	)
Interest expense	$	15,760		$	(5	)	$	-		$	122,418		$	138,173
Depreciation and amortization	$	47,000		$	91,554		$	-		$	-		$	138,554
Identifiable assets	$	1,347,446		$	702,516		$	26		$	165,329		$	2,215,317

				MEDICAL
Year ended	LAND &			DEVICE &		OTHER
June 30, 2017	HOSPITALITY			PHARMA		SERVICES			CORPORATE			TOTAL
Operating revenues, gross	$	39,000		$	1,631,488	$	-		$	-		$	1,670,488
Operating revenues, net	$	39,000		$	890,859	$	-		$	-		$	929,859
Operating income (loss)	$	(2,223	)	$	191,291	$	(32,732	)	$	(484,251	)	$	(327,915	)
Interest expense	$	27,221		$	769	$	-		$	40,094		$	68,084
Depreciation and amortization	$	15,666		$	97,063	$	-		$	-		$	112,729
Identifiable assets	$	1,381,622		$	739,567	$	240		$	789,896		$	2,911,325